Terminated PHASE4 INTERVENTIONAL 2-arm NCT04140396

Continuous Intravenous Lidocaine Infusion Versus Placebo for Rib Fracture Analgesia

A Prospective Comparison of Continuous Intravenous Lidocaine Infusion Versus Placebo for Rib Fracture Analgesia

Sponsor: Stanford University

Interventions Lidocaine infusion Saline infusion

Updated 10 times since 2019 Last updated: Nov 7, 2023 Started: Feb 10, 2020 Primary completion: Nov 9, 2020 Completion: Nov 9, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Lack of personnel and lack of funding for the study drug

Other terminated trials from Stanford University

See all terminations from Stanford University

This PHASE4 trial investigates Rib Fractures and is currently terminated or withdrawn. Stanford University leads this study, which shows 10 recorded versions since 2020 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Dec 2023 — Jul 2024 [monthly]

Terminated PHASE4

Status: Suspended → Terminated
May 2023 — Dec 2023 [monthly]

Suspended PHASE4

Status: Recruiting → Suspended
Feb 2022 — May 2023 [monthly]

Recruiting PHASE4

▶ Show 5 earlier versions

Sep 2021 — Feb 2022 [monthly]

Recruiting PHASE4
May 2021 — Sep 2021 [monthly]

Recruiting PHASE4
Jan 2021 — May 2021 [monthly]

Recruiting PHASE4
Apr 2020 — Jan 2021 [monthly]

Recruiting PHASE4

Status: Not Yet Recruiting → Recruiting
Nov 2019 — Apr 2020 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Stanford University

Data source: Stanford University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Stanford, United States